Tick-borne Encephalitis Virus Real-Time PCR Kit

Product Overview

This in vitro qualitative diagnostic kit is designed for the specific detection of Tick-borne Encephalitis Virus (TBEV) RNA in human serum and cerebrospinal fluid (CSF) specimens. It provides accurate molecular evidence to support early clinical diagnosis of tick-borne encephalitis, a potentially severe neurological infection transmitted primarily through the bite of infected ticks or consumption of unpasteurized dairy products from infected animals. The assay utilizes TaqMan probe-based real-time fluorescent PCR technology. Highly specific primers and dual-labeled hydrolysis probes are designed targeting the conserved polyprotein gene region of Tick-borne Encephalitis Virus. During amplification, the 5'→3' exonuclease activity of Taq polymerase cleaves the probe bound to the template, separating the reporter dye from the quencher dye and generating measurable fluorescent signals detected via the FAM channel. The kit incorporates a human RNase P housekeeping gene internal control detected via the VIC fluorescence channel, which effectively monitors specimen sampling quality, nucleic acid extraction efficiency and potential PCR inhibition, ensuring the validity of each individual test result. This kit delivers exceptional analytical performance with a limit of detection (LOD) of 5 copies per reaction, enabling sensitive identification of low-level viral loads in both serum and CSF samples. It demonstrates high analytical specificity with no cross-reactivity with a comprehensive panel of related pathogens including West Nile Virus, St. Louis Encephalitis Virus, Ebola Virus, Hantaan Virus, Puumala Virus, Seoul Virus, Sin Nombre Virus, Sindbis Virus, Venezuelan Equine Encephalitis Virus and Lassa Virus. The assay exhibits excellent precision with coefficient of variation (CV) values less than 5% for both repeatability and within-laboratory reproducibility. It is fully compatible with all mainstream real-time PCR instruments including Bioperfectus STC-96A, STC-96A PLUS, Applied Biosystems 7500, QuantStudio™ 5, Roche LightCycler® 480, Bio-Rad CFX96™, QIAGEN Rotor-Gene Q and Analytik Jena qTOWER3. The kit is available in two standard specifications: 25 tests per kit (REF: YJC70113NW-25T) and 50 tests per kit (REF: YJC70113NW-50T). All components should be stored at -20±5°C protected from light, and repeated freezing and thawing should be avoided to maintain reagent stability. This CE certified product is intended for professional in vitro diagnostic use only. Test results should be interpreted by trained healthcare professionals in conjunction with patient clinical history, exposure history, signs and symptoms, and other diagnostic findings to support accurate clinical decision-making and appropriate patient management.

Key Features & Advantages

- borne Encephalitis Virus (TBEV) RNA in human serum and cerebrospinal fluid (CSF) specimens. It provides accurate molecular evidence to support early clinical diagnosis of tick - borne encephalitis, a potentially severe neurological infection transmitted primarily through the bite of infected ticks or consumption of unpasteurized dairy products from infected animals. The assay utilizes TaqMan probe - based real - time fluorescent PCR technology. Highly specific primers and dual - labeled hydrolysis probes are designed targeting the conserved polyprotein gene region of Tick - borne Encephalitis Virus. During amplification, the 5'→3' exonuclease activity of Taq polymerase cleaves the probe bound to the template, separating the reporter dye from the quencher dye and generating measurable fluorescent signals detected via the FAM channel. The kit incorporates a human RNase P housekeeping gene internal control detected via the VIC fluorescence channel, which effectively monitors specimen sampling quality, nucleic acid extraction efficiency and potential PCR inhibition, ensuring the validity of each individual test result. This kit delivers exceptional analytical performance with a limit of detection (LOD) of 5 copies per reaction, enabling sensitive identification of low - level viral loads in both serum and CSF samples. It demonstrates high analytical specificity with no cross - reactivity with a comprehensive panel of related pathogens including West Nile Virus, St. Louis Encephalitis Virus, Ebola Virus, Hantaan Virus, Puumala Virus, Seoul Virus, Sin Nombre Virus, Sindbis Virus, Venezuelan Equine Encephalitis Virus and Lassa Virus. The assay exhibits excellent precision with coefficient of variation (CV) values less than 5% for both repeatability and within

Clinical Applications

Clinical laboratories, hospitals, public health departments, and diagnostic testing centers for infectious disease detection.

Comparison & Competitive Advantages

Unlike conventional culture methods that require 48-72 hours for results, this real-time PCR kit delivers definitive pathogen detection in under 2 hours. The molecular method offers superior analytical sensitivity, detecting low-copy-number targets that culture may miss.

Technical Specifications

• limit of detection: (LOD) of 5 copies per reaction, enabling sensitive identification of low-level viral loads in both serum and CSF samples. It demonstrates high analytical specificity with no cross-reactivity with a comprehensive panel of related pathogens including West Nile Virus, St. Louis Encephalitis Virus, Ebola Virus, Hantaan Virus, Puumala Virus, Seoul Virus, Sin Nombre Virus, Sindbis Virus, Venezuelan Equine Encephalitis Virus and Lassa Virus. The assay exhibits excellent precision with coefficient of variation (CV) values less than 5% for both repeatability and within-laboratory reproducibility. It is fully compatible with all mainstream real-time PCR instruments including Bioperfectus STC-96A, STC-96A PLUS, Applied Biosystems 7500, QuantStudio™ 5, Roche LightCycler® 480, Bio-Rad CFX96™, QIAGEN Rotor-Gene Q and Analytik Jena qTOWER3. The kit is available in two standard specifications: 25 tests per kit (REF: YJC70113NW-25T) and 50 tests per kit (REF: YJC70113NW-50T). All components should be stored at -20±5°C protected from light, and repeated freezing and thawing should be avoided to maintain reagent stability. This CE certified product is intended for professional in vitro diagnostic use only. Test results should be interpreted by trained healthcare professionals in conjunction with patient clinical history, exposure history, signs and symptoms, and other diagnostic findings to support accurate clinical decision-making and appropriate patient management.

Frequently Asked Questions

Q: What is the detection limit of this Tick-borne Encephalitis Virus PCR kit?

A: The kit achieves a limit of detection (LOD) of approximately 5 copies per reaction, enabling sensitive identification of low-level infections. This molecular method is significantly more sensitive than conventional culture or antigen-based approaches.

Q: What sample types are compatible with this kit?

A: This kit is optimized for the appropriate clinical specimen type (e.g., stool, blood, swab). The integrated internal control monitors extraction efficiency and detects PCR inhibition, ensuring reliable results across different sample matrices.

Q: How long does the PCR test take?

A: The real-time PCR assay delivers results in approximately 2 hours, compared to 48-72 hours required for conventional culture-based methods. This enables same-day clinical decisions and faster outbreak response.

Q: What instruments is this kit compatible with?

A: The kit is compatible with mainstream real-time PCR instruments including Applied Biosystems 7500, QuantStudio 5, Roche LightCycler 480, Bio-Rad CFX96, QIAGEN Rotor-Gene Q, and Analytik Jena qTOWER3.